By Kate Villars

Acommitment to helping children overcome cancer and a desire to honor a renowned former leader of Dartmouth's Norris Cotton Cancer Center (NCCC) have inspired gifts that will establish two new endowed chairs at DMS, both of them within NCCC. Scott and Lisa Stuart pledged $2.5 million to create a professorship in pediatric oncology, while colleagues, friends, and family of Dr. O. Ross McIntyre have honored the former NCCC director with gifts that will endow a professorship in his name.

Twenty-four DMS faculty members hold endowed chairs, which are considered one of the highest honors in academia. Such professorships are key currency in attracting and retaining top faculty to advance DHMC's three-part mission of research, teaching, and patient care. The funding of additional chairs is a major priority of the $250-million Transforming Medicine Campaign.

"Endowed professorships are vital to our work at Norris Cotton Cancer Center," explains Dr. Mark Israel, director of NCCC. "They provide critical resources to sustain pioneering research and its translation into advances in clinical care that put us at the forefront of patient care nationally.This kind of support has become essential in light of shrinking federal funding for cancer research. Endowed professorships also allow our faculty to dedicate time to our important mission of teaching the next generation of cancer physicians and scientists."

Honoring Ross McIntyre The O. Ross McIntyre, M.D., Endowed Professorship is named for an esteemed longtime NCCC director.Under his leadership from 1974 to 1992, Norris Cotton became highly respected, earning National Cancer Institute designation as one of only 39 comprehensive cancer centers.A noted researcher himself,McIntyre fostered an unusual degree of collaboration among labs.

It was McIntyre's friend and DMS '55 classmate John Moran who initiated the effort to establish the chair. He and McIntyre and their families have remained close over the years, and Moran recognizes the enormous impact of McIntyre's work."Ross was highly

The funding of new chairs is a major priority of the $250-million Transforming Medicine Campaign.

regarded, not only as a caring and highly competent physician and talented investigator, but also as an excellent administrator and a charismatic teacher," says Moran. "There could be no more appropriate way to recognize his contributions." Moran is among over 60 donors to the $2.5-million endowment for the chair.

"I just have a world of respect for the guy," says Steven Gillis, who, with his wife, Anne, made the lead gift commitment to the McIntyre Professorship.

A pioneer in tumor immunology who earned his Ph.D. at Dartmouth in 1978,

Gillis calls McIntyre "a scientific father figure. . . .Ross was important to me because he was a good advisor. He saw the big picture—that the new field of cytokines and cytokine receptors we were working to create was going to explode—that it was bigger than me, it was bigger than the lab where I was doing my doctorate research, it was bigger than Dartmouth, and that it would be far better to have as many advocates and pioneers coming from Dartmouth than to try to control the playing field."

Gillis continued his research at the Fred Hutchinson Cancer Research Center in Seattle. A few years later, he entered the nascent biotech industry, cofounding Immunex Corporation in 1981 and Corixa Corporation in 1994. He has since sold both highly successful companies and now is a managing director at ARCH Venture Partners, a venture capital